H. Michael Hogan Iii.

Director, Otonomy (United States).

Companies

Nabriva Therapeutics plcChief executive officer Jul 10, 2023 to Jul 10, 2023¹
Otonomy (United States)Board member Feb 24, 2023 to Feb 24, 2023²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNabriva Therapeutics plc, Chief executive officer
2
SEC EDGAROtonomy (United States), Board member